This favorable therapeutic profile is primarily attributed to DOX-induced apoptosis.<h4>Conclusions</h4>Our findings demonstrate that tumor-derived exosomes engineered with EGF on their surface enable targeted drug delivery to tumors with high EGFR expression. The gene discussed is EGFR; the disease is neoplasm.